Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

casein kinase Iγ3 Activators

Casein kinase Iγ3 activators constitute a specialized group of compounds that are designed to enhance the activity of casein kinase I gamma 3 (CKIγ3), an enzyme that plays a significant role in various cellular processes, including signal transduction, cell proliferation, and circadian rhythms. These activators can increase the phosphorylation capabilities of CKIγ3, thereby amplifying its role in the phosphorylation of specific substrates. The activation of CKIγ3 can be achieved through several mechanisms. Some activators bind to the regulatory regions of the enzyme, inducing a conformational change that can lead to an increase in its catalytic activity. Others may interact with the ATP-binding site, facilitating ATP's role in the transfer of phosphate groups to the enzyme's substrates. These activators are often small molecules that have been identified or synthesized following extensive research into the structure and dynamics of CKIγ3, allowing for precise interaction with the enzyme's active site or allosteric sites.

The discovery and development of casein kinase Iγ3 activators involve various methods, including high-throughput screening of chemical libraries to identify molecules that can enhance the enzyme's activity. Once potential activators are identified, they can be further optimized through medicinal chemistry efforts to improve their potency, selectivity, and cellular activity. Computational modeling and structure-activity relationship (SAR) studies also play a crucial role in designing molecules that can effectively increase CKIγ3 activity. These activators can have diverse chemical structures, with careful consideration given to their ability to penetrate cells and reach the intracellular environment where CKIγ3 is located.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin raises intracellular cAMP levels, which can lead to the activation of Protein Kinase A (PKA). Casein kinase Iγ3, being a kinase, can be indirectly activated through PKA-mediated phosphorylation events in overlapping signaling cascades.

Casein Kinase I Inhibitor, D4476

301836-43-1sc-202522
1 mg
$99.00
6
(1)

D4476 is a specific inhibitor of casein kinase I. It is used here in a contrary role to suggest that, in a competitive environment, the presence of D4476 could lead to a compensatory increase in the activity of casein kinase Iγ3 to maintain cellular functions.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

BIO-acetoxime is a selective glycogen synthase kinase 3 (GSK-3) inhibitor, which can lead to the activation of Wnt signaling. Activation of Wnt signaling may indirectly enhance the function of casein kinase Iγ3, which is known to phosphorylate components of the pathway.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

PD 0332991 is a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6). Inhibition of CDK4/6 can alter cell cycle regulation and might indirectly upregulate the activity of casein kinase Iγ3 as a compensatory mechanism in cell cycle progression.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK). Inhibiting ROCK can lead to changes in the actin cytoskeleton and potentially enhance casein kinase Iγ3 activity as part of compensatory cytoskeletal regulation.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

SB 216763 is an inhibitor of GSK-3, which can activate the Wnt signaling pathway. This activation may lead to the functional enhancement of casein kinase Iγ3 due to its role in phosphorylating components within the Wnt pathway.

Piceatannol

10083-24-6sc-200610
sc-200610A
sc-200610B
1 mg
5 mg
25 mg
$51.00
$71.00
$199.00
11
(2)

Piceatannol inhibits Syk kinase, which could lead to altered signaling cascades. These changes can potentially enhance the activity of casein kinase Iγ3 indirectly, as the cellular signaling environment adjusts to the inhibition of Syk.